After the role of CD47 in the process of tumor cell evasion from the immune system had been disclosed, targeting CD47 has become a novel strategy for treatment, and various anti-CD47 antibodies have been reported, such as Hu5F9-G4, ZF1, B6H12 antibodies, etc. [15,29,30]. The gene discussed is CD47; the disease is neoplasm.